Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 41, 2008, Pages 15708-15713

  Fushimi, Kazuo ^a   Ray, Payal ^a   Kar, Amar ^a   Wang, Lei ^a   Sutherland, Leslie C ^b   Wu, Jane Y ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SUDBURY REGIONAL HOSPITAL   (Canada)

Author keywords

Alternative splicing regulation; Cancer; Cell death; RNA binding protein

Indexed keywords

CAP BINDING PROTEIN; CASPASE 2; MESSENGER RNA; RBM 5 PROTEIN; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; RNA BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING ASSAY; CARCINOGENESIS; CELL DEATH; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN RNA BINDING; REPRESSOR GENE; RNA SPLICING; TUMOR SUPPRESSOR GENE; UPREGULATION;

ALTERNATIVE SPLICING; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; CASPASE 2; CELL CYCLE PROTEINS; CELL LINE; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; PROTEIN BINDING; PROTEIN ISOFORMS; RNA PRECURSORS; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 57349185582     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805569105     Document Type: Article

References (54)

1. Kumar S (2007) Caspase function in programmed cell death. Cell Death Differ 14:32-43.
2. Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897-907.
3. Salvesen GS, Abrams JM (2004) Caspase activation: Stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene 23:2774-2784.
4. Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD (2006) Caspase-2-induced apoptosis requires bid cleavage: A physiological role for bid in heat shock-induced death. Mol Biol Cell 17:2150-2157.
5. Lavrik IN, Golks A, Baumann S, Krammer PH (2006) Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood 108:559-565.
6. Lin CF, et al. (2004) Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide- and etoposide-induced apoptosis. J Biol Chem 279:40755-40761.
7. Paroni G, Henderson C, Schneider C, Brancolini C (2001) Caspase-2-induced apoptosis depends on caspase-9, but its processing during UV- or tumor necrosis factor-dependent cell death requires caspase-3. J Biol Chem 276:21907-21915.
8. Poh TW, Pervaiz S (2005) LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Cancer Res 65:6264-6274.
9. Shin S, et al. (2005) Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24:3532-3542.
10. Tamm C, Zhivotovsky B, Ceccatelli S (2008) Caspase-2 activation in neural stem cells undergoing oxidative stress-induced apoptosis. Apoptosis 13:354-363.
11. Tu S, et al. (2006) In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol 8:72-77.
12. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B (2006) Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 25:5683-5692.
13. Wagner KW, Engels IH, Deveraux QL (2004) Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway. J Biol Chem 279:35047-35052.
14. Kumar S, Kinoshita M, Noda M (1997) Characterization of amammalian cell death gene Nedd2. Leukemia 11:385-386.
15. Wang L, Miura M, Bergeron L, Zhu H, Yuan J (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-750.
16. Droin N, Beauchemin M, Solary E, Bertrand R (2000) Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade. Cancer Res 60:7039-7047.
17. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM (2003) Overexpression of the antiapoptotic caspase-2 short isoform in macrophage-derived foam cells of human atherosclerotic plaques. Am J Pathol 162:731-736.
18. Parent N, Sane AT, Droin N, Bertrand R (2005) Procaspase-2S inhibits procaspase-3 processing and activation, preventing ROCK-1-mediated apoptotic blebbing and body formation in human B lymphoma Namalwa cells. Apoptosis 10:313-322.
19. Bergeron L, et al. (1998) Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12:1304-1314.
20. Cote J, Dupuis S, Jiang Z, Wu JY (2001) Caspase-2 pre-mRNA alternative splicing: Identification of an intronic element containing a decoy 3′ acceptor site. Proc Natl Acad Sci USA 98:938-943.
21. Cote J, Dupuis S, Wu JY (2001) Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion. J Biol Chem 276:8535-8543.
22. Havlioglu N, et al. (2007) An intronic signal for alternative splicing in the human genome. PLoS ONE 2:e1246.
23. Lerman MI, Minna JD (2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p213 Tumor Suppressor Gene Consortium. Cancer Res 60:6116-6133.
24. Oh JJ, Koegel AK, Phan DT, Razfar A, Slamon DJ (2007) The two single-nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers. Lung Cancer 58:7-14.
25. Oh JJ, West AR, Fishbein MC, Slamon DJ (2002) The two single-nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers. Cancer Res 62:3207-3213.
26. Edamatsu H, Kaziro Y, Itoh H (2000) LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells. Genes Cells 5:849-858.
27. Mourtada-Maarabouni M, Sutherland LC, Meredith JM, Williams GT (2003) Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5. Genes Cells 8:109-119.
28. Mourtada-Maarabouni M, Sutherland LC, Williams GT (2002) Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways. Apoptosis 7:421-432.
29. Oh JJ, et al. (2006) 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res 66:3419-3427.
30. Jiang ZH, Zhang WJ, Rao Y, Wu JY (1998) Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc Natl Acad Sci USA 95:9155-9160.
31. Rintala-Maki ND, Abrasonis V, Burd M, Sutherland LC (2004) Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis. Cell Biochem Funct 22:307-313.
32. Rintala-Maki ND, Sutherland LC (2004) LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis 9:475-484.
33. Sutherland LC, et al. (2000) LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene 19:3774-3781.
34. Drabkin HA, et al. (1999) DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene 18:2589-2597.
35. Behzadnia N, et al. (2007) Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes. EMBO J 26:1737-1748.
36. Chen YI, et al. (2007) Proteomic analysis of in vivo assembled pre-mRNA splicing complexes expands the catalog of participating factors. Nucleic Acids Res 35:3928-3944.
37. Sutherland LC, Rintala-Maki ND, White RD, Morin CD (2005) RNA binding motif (RBM) proteins: A novel family of apoptosis modulators? J Cell Biochem 94:5-24.
38. Rintala-Maki ND, et al. (2007) Expression of RBM5-related factors in primary breast tissue. J Cell Biochem 100:1440-1458.
39. Blencowe BJ (2006) Alternative splicing: New insights from global analyses. Cell 126:37-47.
40. Gardina PJ, et al. (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole-genome exon array. BMC Genomics 7:325.
41. Li C, et al. (2006) Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Res 66:1990-1999.
42. Zhang C, et al. (2006) Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 7:202.
43. Wu JY, Tang H, Havlioglu N (2003) Alternative pre-mRNA splicing and regulation of programmed cell death. Prog Mol Subcell Biol 31:153-185.
44. Izquierdo JM, et al. (2005) Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell 19:475-484.
45. Izquierdo JM, Valcarcel J (2007) Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing. J Biol Chem 282:1539-1543.
46. Fushimi K, Osumi N, Tsukahara T (2005) NSSRs/TASRs/SRp38s function as splicing modulators via binding to pre-mRNAs. Genes Cells 10:531-541.
47. Komatsu M, Kominami E, Arahata K, Tsukahara T (1999) Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurones. Genes Cells 4:593-606.
48. Yang L, Embree LJ, Hickstein DD (2000) TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 20:3345-3354.
49. Chen W, Itoyama T, Chaganti RS (2001) Splicing factor SRP20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma. Genes Chromosomes Cancer 32:281-284.
50. McGarvey T, et al. (2000) The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J Cell Biol 150:309-320.
51. Karni R, et al. (2007) The gene encoding the splicing factor SF2/ASF is a protooncogene. Nat Struct Mol Biol 14:185-193.
52. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
53. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660.
54. Bonnal S, et al. (2008) RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition. Mol Cell, in press.